These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27322375)

  • 21. Serum concentrations of interleukin-2 and tumour necrosis factor-α under cyclosporine versus acitretin treatment in plaque-type psoriasis.
    Akçali C; Guven EH; Kirtak N; Inaloz HS; Ozgoztasi O; Guvenc U
    J Int Med Res; 2014 Oct; 42(5):1118-22. PubMed ID: 25143337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of moderate-to-severe plaque psoriasis.
    Salgo R; Thaçi D
    G Ital Dermatol Venereol; 2009 Dec; 144(6):701-11. PubMed ID: 19907408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.
    Menter A; Korman NJ; Elmets CA; Feldman SR; Gelfand JM; Gordon KB; Gottlieb AB; Koo JY; Lebwohl M; Lim HW; Van Voorhees AS; Beutner KR; Bhushan R
    J Am Acad Dermatol; 2009 Sep; 61(3):451-85. PubMed ID: 19493586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New guidelines for managing psoriasis with systemic medications.
    Dermatol Nurs; 2009; 21(5):301-3. PubMed ID: 19873700
    [No Abstract]   [Full Text] [Related]  

  • 25. Optimizing care for psoriatic patients requiring systemic therapies: how will COVID-19 disease transform risk perceptions?
    Talamonti M; Tofani L; Bianchi L; Galluzzo M
    Arch Dermatol Res; 2021 Mar; 313(2):127-128. PubMed ID: 32647977
    [No Abstract]   [Full Text] [Related]  

  • 26. Evidence-based recommendations on conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists.
    Paul C; Gallini A; Maza A; Montaudié H; Sbidian E; Aractingi S; Aubin F; Bachelez H; Cribier B; Joly P; Jullien D; Le Maître M; Misery L; Richard MA; Ortonne JP
    J Eur Acad Dermatol Venereol; 2011 May; 25 Suppl 2():2-11. PubMed ID: 21388453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 'switcher' patient profile in psoriasis treatment: from traditional to biological and from biological to traditional systemic drugs.
    Tabolli S; Giannantoni P; Paradisi A; Abeni D
    Br J Dermatol; 2015 Jul; 173(1):256-8. PubMed ID: 25422080
    [No Abstract]   [Full Text] [Related]  

  • 28. [Guidelines on the use of methotrexate in psoriasis].
    Carretero G; Puig L; Dehesa L; Carrascosa JM; Ribera M; Sánchez-Regaña M; Daudén E; Vidal D; Alsina M; Muñoz-Santos C; López-Estebaranz JL; Notario J; Ferrandiz C; Vanaclocha F; García-Bustinduy M; Taberner R; Belinchón I; Sánchez-Carazo J; Moreno JC;
    Actas Dermosifiliogr; 2010 Sep; 101(7):600-13. PubMed ID: 20858386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translating psoriasis treatment guidelines into clinical practice - the need for educational interventions and strategies for broad dissemination.
    Nast A; Erdmann R; Pathirana D; Rzany B
    J Eval Clin Pract; 2008 Oct; 14(5):803-6. PubMed ID: 19018914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expert report on psoriasis: Spanish dermatologists' opinions on the use of biologic agents to manage moderate to severe psoriasis in adults.
    Puig L; de la Cueva P; Linares M; Suarez J; Velasco M; Vidal D; Zulaica A; García-Calvo C
    Actas Dermosifiliogr; 2013 Jun; 104(5):400-8. PubMed ID: 23669590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-G 14-bp polymorphism: a possible marker of systemic treatment response in psoriasis vulgaris? Preliminary results of a retrospective study.
    Borghi A; Rizzo R; Corazza M; Bertoldi AM; Bortolotti D; Sturabotti G; Virgili A; Di Luca D
    Dermatol Ther; 2014; 27(5):284-9. PubMed ID: 24909182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics and systemic therapies administered to first-time patients at a tertiary psoriasis outpatient clinic.
    Bonifati C; Graceffa D; Lora V; Maiani E
    G Ital Dermatol Venereol; 2016 Dec; 151(6):596-602. PubMed ID: 26505567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
    Daudén E; Puig L; Ferrándiz C; Sánchez-Carazo JL; Hernanz-Hermosa JM;
    J Eur Acad Dermatol Venereol; 2016 Mar; 30 Suppl 2():1-18. PubMed ID: 26812550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A global approach to psoriatic patients through PASI score and Skindex-29.
    Prignano F; Ruffo G; Ricceri F; Pescitelli L; Lotti T
    G Ital Dermatol Venereol; 2011 Feb; 146(1):47-52. PubMed ID: 21317856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient Adherence to Biologic Agents in Psoriasis.
    Hsu DY; Gniadecki R
    Dermatology; 2016; 232(3):326-33. PubMed ID: 27093295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology.
    Arnone M; Takahashi MDF; Carvalho AVE; Bernardo WM; Bressan AL; Ramos AMC; Terena AC; Souza CDS; Nunes DH; Bortoletto MCC; Oliveira MFSP; Neffá JM; Fieri LC; Azulay-Abulafia L; Felix PAO; Magalhaes RF; Romiti R; Jaime TJ
    An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):76-107. PubMed ID: 31166402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Use of Methotrexate, Alone or in Combination With Other Therapies, for the Treatment of Palmoplantar Psoriasis.
    Wald JM; Klufas DM; Strober BE
    J Drugs Dermatol; 2015 Aug; 14(8):888-92. PubMed ID: 26267735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Systemic therapy in the treatment of psoriasis: drugs of prebiological era].
    Kurilić M; Prpić-Massari L; Brajac I; Kastelan M
    Lijec Vjesn; 2010; 132(7-8):246-51. PubMed ID: 20857811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporine in psoriasis: comparison of a 25-year real-world Italian experience to current European guidelines.
    Altomare G; Ayala F; Bardazzi F; Bellia G; Chimenti S; Colombo D; Flori ML; Girolomoni G; Micali G; Parodi A; Peris K; Vena GA
    G Ital Dermatol Venereol; 2016 Aug; 151(4):432-5. PubMed ID: 25786483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging oral drugs for psoriasis.
    Mahmood T; Zaghi D; Menter A
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):209-20. PubMed ID: 25643592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.